Cross-disciplinary approaches for measuring parasitic helminth viability and phenotype

Anais da Academia Brasileira de Ciencias

Volumn 83, Issue 2, 2011, Pages 649-662

  Peak, Emily ^a   Hoffmann, Karl F ^a  

^a ABERYSTWYTH UNIVERSITY   (United Kingdom)

Author keywords

Helminth; Nematode; Phenotype; Schistosome; Viability

Indexed keywords

ANIMALIA; EUKARYOTA; NEMATODA; PLATYHELMINTHES; SCHISTOSOMA; VERMES;

EID: 79959320834     PISSN: 00013765     EISSN: 16782690     Source Type: Journal    
DOI: 10.1590/s0001-37652011000200024     Document Type: Article

References (70)

1. Abdulla MH, Ruelas DS, Wolff B, Snedecor J, Lim KC, Xu F, Renslo AR, Williams J, Mckerrow JH and Caffrey CR. 2009. Drug Discovery forSchistosomiasis: Hit and Lead Compounds Identified in a Library of Known Drugs by Medium-Throughput Phenotypic Screening. PLoS Negl Trop Dis 3: e478.
2. Abraham VC, Taylor DL and Haskins JR. 2003. High content screening applied to large-scale cell biology. Trends Biotechnol 22: 15-22.
3. Ahmann FR, Garewal HS, Schifman R, Celniker A and Rodney S. 1987. Intracellular adenosine triphosphate as a measure of human tumor cell viability and drug modulated growth. In Vitro Cell Dev Biol Plant 23: 474-480.
4. Arndt S, Seebach J, Psathanki K, Galla H-J and Wegener J. 2004. Bioelectrical impedance assay to monitor changes in cell shape during apoptosis. Biosens Bioelectron 19: 583-594.
5. Bennett JL and Pax RA. 1986. Micromotility meter: an instrument designed to evaluate the action of drugs on motility of larval and adult nematodes. Parasitology 93: 341-346.
6. Berriman M, Haas BJ, Loverde PT, Wilson RA, Dillon GP, Cerqueira GC, Mashiyama ST, Allazikani B, Andrade LF and Ashton PD. 2009. The genome of the blood fluke Schistosoma mansoni. Nature 460: 352-358.
7. Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, Diemert D and Hotez PJ. 2006. Soiltransmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 367: 1521-1532.
8. Brindley PJ and Pearce EJ. 2007. Genetic manipulation of schistosomes. Int J for Parasitol 37: 465-473.
9. Butterworth AE, Taylor DW, Veith MC, Vadas MA, Dessein A, Sturrock RF and WELLS E. 1982. Studies on the mechanisms of immunity in human schistosomiasis. Immunol Rev 61: 5-39.
10. Caffrey CR. 2007. Chemotherapy of schistosomiasis: present and future. Curr Opin Chem Biol 11: 433-439.
11. Cathcart MD. 1906. Upon the reduction of methylene blue by cow's milk. J Hyg 6: 300-303.
12. CODER D. 1997. Assessment of cell viability. In: CURRENT PROTOCOLS IN CYTOMETRY. J Wiley & Sons, Inc, p. 9.2.1-9.2.14.
13. Comley JC, Rees MJ, Turner CH and Jenkins DC. 1989. Colorimetric quantitation of filarial viability. Int J Parasitol 19: 77-83.
14. Cook JA and Mitchell JB. 1989. Viability measurements in mammalian cell systems. Anal Biochem 179: 1-7.
15. Culloty SC, Novoa B, Pernas M, Longshaw M, Mulcahy MF, Feist SW and FIGUERAS A. 1999. Susceptibility of a number of bivalve species to the protozoan parasite Bonamia ostreae and their ability to act as vectors for this parasite. Dis Aquat Org 37: 73-80.
16. Davis WC, Wyatt CR, Hamilton MJ and Goff WL. 1992. A rapid reliable method of evaluating growth andviability of intraerythrocytic protozoan hemoparasites using fluorescence flow cytometry. Mem Inst Oswaldo Cruz, Rio de Janeiro 87: 235-239.
17. Decherchi P, Cochard P and Gauthier P. 1997. Dual staining assessment of Schwann cell viability within whole peripheral nerves using calcein-AM and ethidium homodimer. J Neurosci Methods 71: 205-213.
18. Doenhoff MJ, Hagan P, Cioli D, Southgate V, Pica-Mattoccia L, Botros S, Coles G, Tchuem Tchuenté LA, Mbaye A and Engels D. 2009. Praziquantel:its use in control of schistosomiasis in sub- Saharan Africa and current research needs. Parasitology 136: 1825-1835.
19. Folz SD, Pax RA, Thomas EM, Bennett JL, Lee BL and Conder GA. 1987. Detecting in vitro anthelmintic effects with a micromotility meter. Vet Parasitol 24: 241-250.
20. Giaever I and Keese CR. 1993. A morphological biosensor for mammalian cells. Nature 366: 591-592.
21. Gill MS, Olsen A, Sampayo JN and Lithgow GJ. 2003. An automated high-throughput assay for survival of the nematode Caenorhabditis elegans. Free Radic Biol Med 35: 558-565.
22. Gloeckner C, Garner AL, Mersha F, Oksov Y, Tricoche N, Eubanks LM, Lustigman S, Kaufmann GF and Janda KD. 2010. Repositioning of an existing drug for the neglected tropical disease Onchocerciasis. Proc Natl Acad Sci USA 107: 3424.
23. Gold D. 1997. Assessment of the viability of Schistosoma mansoni schistosomula by comparative uptake of various vital dyes. Parasitol Res 83: 163-169.
24. Gold D and Flescher E. 2000. Influence of mechanical tail-detachment techniques of schistosome cercariaeon the production, viability, and infectivity of resultant schistosomula: a comparative study. Parasitol Res 86: 570-572.
25. Gould MK, Vu XL, Seebeck T and De Koning HP. 2008. Propidium iodide-based methods for monitoring drug action in the kinetoplastidae: comparison with the Alamar Blue assay. Anal Biochem 382: 87-93.
26. Gut J, Ang KKH, Legac J, Arkin MR, Rosenthal PJ and Mckerrow JH. 2011. An image-based assay for high throughput screening of Giardia lamblia. J Microbiol Meth 84: 398-405.
27. Haeberlein S and Haas W. 2008. Chemical attractants of human skin for swimming Schistosoma mansoni cercariae. Parasitol Res 102: 657-662.
28. Harper BL, Fine DP, Guckian JC and Cavallo T. 1981. Trypan blue inhibition of complement receptor funtion on various cells. Immunology 62: 61-66.
29. Hokke CH, Fitzpatrick JM and Hoffmann KF. 2007. Integrating transcriptome, proteome and glycome analyses of Schistosoma biology. Trends Parasitol 23: 165-174.
30. Hotez PJ and Fenwick A. 2009. Schistosomiasis in Africa: an emerging tragedy in our new global health decade. PLoS Negl Trop Dis 3: e485-e489.
31. Hutter KJ and Eipel HE. 1978. Advances in Determination of Cell Viability. J Gen Microbiol 107: 165- 167.
32. +] rise in maintaining viability of yeast cells late in the mating pheromone response pathway. J Biol Chem 265: 13391- 13399.
33. Jones K and Senft J. 1985. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. J Histochem Cytochem 33: 77-79.
34. Keiser J. 2009. In vitro and in vivo trematode models for chemotherapeutic studies. Parasitology 137: 589-603.
35. King CH, Dickman K and Tisch DJ. 2005. Reassessment of the cost of chronic helmintic infection: a metaanalysis of disability-related outcomes in endemic schistosomiasis. Lancet 365: 1561-1569.
36. Kuntz AN, Davioud-Charvet E, Sayed AA, Califf LL, Dessolin J, Arnér ES and Williams DL. 2007. Thioredoxin Glutathione Reductase from Schisto-soma mansoni: An Essential Parasite Enzyme and a Key Drug Target. PLoS Medicine 4: e206.
37. Levitz SM and Diamond RD. 1985. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. J Infect Dis 152: 938-945.
38. Lloyd D, Harris JC, Biagini GA, Hughes MR, Maroulis S, Bernard C, WADLEY RB and EDWARDS MR. 2004. The plasma membrane of micoraerophilic protists: oxidative and nitrosative stress. Microbiology 150: 1183-1190.
39. Loukas A and Bethony JM. 2008. New drugs for an ancient parasite. Nature Med 14: 365-367.
40. Lyddiard JRA, Bartlett A, Gray B AND Whitfield PJ. 1998. The use of video-imaging to assesss the sublethal impact of plant secondary compounds on Schistosoma mansoni miracidia. J Helminthol 72: 237-241.
41. Magalhaes LG, Machado CB, Morais ER, Bueno DE, Carvalho Moreira E, Soares CS, Da Silva SH, Da Silva Filho AA and Rodrigues V. 2009. In vitro schistosomicidal activity of curcumin against Schistosoma mansoni adult worms. Parasitol Res 104: 1197- 1201.
42. Mansour NR and Bickle QD. 2010. Comparison of microscopy and Alamar blue reduction in a larval based assay for schistosome drug screening. PLoS Negl Trop Dis 4: e795.
43. Marie-Magdeleine C, Udino L, Philibert L, Bocage B and Archimede H. 2010. In vitro effects of cassava(Manihot esculenta) leaf extracts on four developmental stages of Haemonchus controtus. Vet Parasitol 173: 85- 92.
44. Miller MA, Mcgowan SE, Gantt KR, Champion M, Novick SL, Andersen KA, Bacchi CJ, Yarlett N, Britigan BE and Wilson ME. 2000. Inducible resistance to oxidant stress in the protozoan Leishmania chagasi. J Biol Chem 275: 33883-33889.
45. Mohr LR and Trountson AO. 1980. The use of fluorescein diacetate to assess embyro viability in the mouse. J Reprod Fertil 58: 189-196.
46. Monks A ET AL. 1991. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 83: 757-766.
47. Ng AYJ, Rajapakse JC, Welsch RE, Matsudaira PT, Horodincu V and Evans JG. 2010. A Cell Profiling Framework for Modeling Drug Responses from HCS Imaging. J Biomol Screen 15: 858.
48. Nyame AK, Lewis FA, Doughty BL, Correa-Oliveira R and Cummings RD. 2003. Immunity to schistosomiasis: glycans are potential antigenic targets for immune intervention. Exp Parasitol 104: 1-13.
49. Owen J, Slocombe D, Cote JF and De Gannes RVG. 2008. The persistence of benzimidazole-resistant cyathostomes on horse farms in Ontario over 10 years andthe effectiveness of ivermectin and moxidectin against these resistant strains. Can Vet J 49: 56-60.
50. Park J-C, Hwang Y-S and Suh H. 2000. Viability evaluation of engineered tissues. Yonsei Med J 41: 836-844.
51. Peak E, Chalmers IW and Hoffmann KF. 2010. Development and Validation of a Quantitative, High-Throughput, Fluorescent-Based Bioassay to Detect Schistosoma Viability. PLoS Negl Trop Dis 4: e759.
52. Pichugin Y, Fahy GM and Morin R. 2006. Cryopreservation of rat hippocampal slices by vitrification. Cryobiology 52: 228-240.
53. Rai G ET AL. 2009. Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasis. J Med Chem 52: 6474-6483.
54. Rotman B and Papermaster BW. 1966. Membrane Properties of Living Mammalian Cells as Studied by Enzymatic Hydrolysis of Fluorogenic Esters. Proc Natl Acad Sci USA 55: 134-141.
55. Sayed AA, Simeonov A, Thomas CJ, Inglese J, Austin CP and Williams DL. 2008. Identification of oxadiazoles as new drug leads for the control of schistosomiasis. Nature Med 14: 407-412.
56. Schnurer J and Rosswall T. 1982. Fluorescein diacetate hydrolysis as a measure of total microbial activity in soil and litter. Appl Environ Microbiol 43: 1256-1261.
57. Schupp DG and Erlandsen SL. 1987. A new method to determine Giardia Cyst viability: correlation of fluorescein diacetate and propidium iodide staining with animal infectivity. Appl Environ Microbiol 53: 704-707.
58. Silvestre A, Leignel V, Berrag B, Gasnier N, Humbert J-F, Chartier C and Cabaret J. 2002. Sheep and goat nematode resistance to anthelmintics: pro and cons among breeding management factors. Vet Res 33.
59. Simeonov A, Jadhav A, Sayed AA, Wang Y, Nelson ME, Thomas CJ, Inglese J, Williams DL and Austin CP. 2008. Quantitative High-Throughput Screen Identifies Inhibitors of the Schistosoma mansoni Redox Cascade. PLoS Negl Trop Dis 2.
60. Skelly PJ and Wilson RA. 2006. Making sense of the schistosome surface. Adv Parasitol 63: 185-284.
61. Smout MJ, Kotze AC, Mccarthy JS and Loukas A. 2010. A novel high throughput assay for anthelmintic drug screening and resistance diagnosis by real-time monitoring of parasite motility. PLoS Negl Trop Dis 4: e885.
62. Štefani S, DvǒRák J, Horn M, Braschi S, Sojka D, Ruelas D, Suzuki B, Lim KC, Hopkins SD and Mckerrow JH. 2010. RNA Interference in Schistosoma mansoni Schistosomula: Selectivity, Sensitivity and Operation for Larger-Scale Screening. PLoS Negl Trop Dis 4: e850.
63. Tian H, Ip L, Luo H, Chang DC and Luo KQ. 2007. A high throughput drug screen based on fluorescence resonanceenergy transfer (FRET) for anticancer activity of compounds from herbal medicine. Br J Pharmacol 150: 321-334.
64. Totino PRR, Daniel-Ribeiro CT, Corte-Real S and De Fatima Ferreira-Da-Cruz M. 2008. Plasmodium falciparum: erythrocytic stages die by autophagic-like cell death under drug pressure. Exp Parasitol 118: 478-486.
65. Van Der Linden PWG and Deelder AM. 1984. Schistosoma mansoni: A Diamidinophenylindole Probe for in Vitro Death of Schistosomula. Exp Parasitol 57: 125-131.
66. Wegener J, Keese CR and Giaever I. 2000. Electric cell-substrate impedance sensing (ECIS) as a noninvasive means to monitor the kinetics of cell spreading to artificial surfaces. Exp Cell Res 259: 158-166.
67. Wolstenholme AJ, Fairweather I, Prichard R, Von Samson-Himmelstjerna G and Sangster NC. 2004. Drug resistance in veterinary helminths. Trends Parasitol 20: 469-476.
68. Woods DJ and Knauer CS. 2010. Discovery of veterinary antiparasitic agents in the 21st century: a view from industry. Int J Parasitol 40: 1177-1181.
69. Yamada A, Gaja N, Ohya S, Katsuhiko M, Narita H, Ohwada T and Imaizumi Y. 2001. Usefulness and limitation of DiBAC4(3), a voltage-sensitive fluorescent dye, for the measurement of membrane potentials regulated by recombinant large conductance Ca2+-activated K+ channels in HEK293 cells. Jpn. J Pharmacol 86: 342-350.
70. Zhou Y, Zheng H, Chen Y, Zhang L, Wang K, Guo J, Huang Z, Zhang B, Huang W and Jin K. 2009. The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature 460: 345-351.